A 2009 journal article – promoted in a news release by the journal – and picked up by many news organizations – has now been retracted by the authors.
But now the journal issued no news release about the retraction – an issue of transparency that the RW blog raises.
And you can guess how much news coverage the retraction will get.
And this was all over a molecule that could supposedly “make breast tumors respond to a drug to which they’re not normally susceptible” – as the RW blog put it. But it was also a molecule, RW points out, that wasn’t even in clinical trials yet.
He/she who lives by the journal news release risks one’s longterm credibility.